Sleep Apnea Disorder/ [ Press Release ]/ Carrollton, TX /Practice Start-up Kit available at the Chicago Midwinter Show February 24-26 . Patterson Dental and Airway Management, Inc., have entered into a strategic partnership to distribute the leading custom oral appliance for treating sleep apnea to dental professionals through Patterson Dental. A Practice Start-up Kit will be available for the first time at the Chicago Dental Society 146th Midwinter Meeting February 24-26 at the Patterson booth. The kit is designed to give dental professionals all the tools needed to immediately start treatment for snoring and sleep apnea.
Through Patterson Dental and Airway Management, a world leader in the design, manufacture and sales of custom oral appliances with its Thornton Adjustable Positioner (TAP® 3 appliance), dentists have a proven treatment modality for patients suffering from snoring and Obstructive Sleep Apnea (OSA). The TAP® fits over the teeth similar to a mouth guard and advances the jaw forward during sleep, keeping the airway open and eliminating snoring and sleep apnea. Read the rest of this entry
SleepApneaDisorder/[ Press Release ]/ Cortex Pharmaceuticals, Inc. announced top-line results from an exploratory clinical study with its AMPAKINE® compound, CX1739 in subjects with sleep apnea. The study enrolled 20 relatively healthy adults with moderate-to-severe obstructive sleep apnea, 16 of which were administered a single oral dose of CX1739 and 4 of which received matching placebo for one night.
The objective of the study was to further explore safety and tolerability in the sleep apnea population, as well as to assess putative efficacy of CX1739 on a range of sleep apnea parameters assessed by overnight polysomnography.
The study demonstrated that selected oxygen saturation parameters were statistically improved by one dose of CX1739, but the interpretation of these results was complicated by a reduced sleep time during the night following drug treatment.
CX1739 did not reduce the mean apnea/hypopnea index (AHI; frequency of apnea or hypopnea events per hour of sleep). However, in the AHI responder analysis, defined as a greater than 40% reduction in the AHI, three subjects (20%) in the CX1739 treatment group were responders, and there were no responders in the placebo group. Read the rest of this entry
Sleep apnea is a deadly sleep disorder that involves short periods of not breathing while sleeping. It is quite often associated with loud snoring, fatigue , daytime sleepiness. Popular traditional sleep apnea treatments are based on drugs, breathing machines, oral appliances and surgery. However, specific breathing exercises may also help overcoming sleep apnea.
Obstructive sleep apnea occurs when throat muscles relax, and central sleep apnea, when your brain does not properly signal the muscles that control breathing. Obstructive sleep apnea risk factors include excess weight, large neck circumference, hypertension, narrowed airway, smoking, or being male or over 65. The central type risk factors include stroke or brain tumor, heart problems, or being male or older.
The upper airway muscle function is involved in maintenance of the upper airway and contributes to obstructive sleep apnea syndrome, or OSAS. Researchers in Brazil studied it and published their findings in 2009 in the “American Journal of Respiratory and Critical Care Medicine.
Thirty-one patients with moderate OSAS were divided into intervention and control groups. The intervention group performed a set of daily orophyaryngeal exercises involving the tongue, soft palate and lateral pharyngeal wall for three months.
Patients in the intervention group had a significant decrease in neck circumference, snoring intensity, daytime sleepiness and sleep quality. The researchers believe that these exercises, derived from speech therapy, may be an effective treatment option.
A sleep apnea machine is today’s more effective treatment solution for obstructive sleep apnea. If you are a sleep apnea patient and have just lately been using a sleep apnea machine, you might need to know if you are executing the treatment methods appropriately. Sleep apnea therapy that is appropriately done could make the treatment method do the job almost 100% in order to avoid apnea episodes.
First, check if you are getting the correct quantity of pressure prescribed. Additionally, just be sure you are using the sleep apnea machine as often as recommended, which in most of the cases, it must be used every night. Compliance to the particular prescribed therapy is very important to acquire good benefits. The machine quite possibly cost you thousands of dollars so you might as well put it to use and use it right. Typically, you can get the insurance to cover the cost of the machines or perhaps greater part of the cost of it. Read the rest of this entry
There are 10 drugs (total 78 reports) most commonly used by sleep apnea patients. Reports reveal that there are many side effects, drug interactions, and effectiveness can not be detected when drugs are approved. They may be found only after drugs have been used by millions of people and for a long time. Patients and health professionals alone are not able to conduct these large, long term studies.
The following drugs are reported to be used in the treatment of Sleep Apnea. Click to see how effective they are overall and in long term (1+ year), and for what kind of people:
A recently concluded research at the University of Toronto could provide good and healthy sleepful nights for the 18 million North Americans who suffer from obstructive sleep apnea.
In a recent study that appeared in the Journal of Neuroscience, scientists from the University of Toronto demonstrated that repeated obstruction of the airways requires release of the brain chemical noradrenaline. The release of this chemical helps the brain learn to breathe more effectively and purposefully. Read the rest of this entry
What is sleep apnea is a non-branded, non-commercial educational video created by the American Sleep Apnea Association to educate patients and public about sleep apnea.
The video describes the symptoms of the condition, how it is diagnosed and what are the treatment options.
Using a CPAP while sleeping is the most common treatment. And the machines can be expensive. Prices vary greatly, but generally range from $1,500 to $3,000.
SecondWindCPAP in Tracy, Minn. provides free machines to those in need through a partnership with the American Sleep Apnea Association. The nonprofit association will send you a receipt for your tax-deductible contribution. It also collects cash donations to keep the program going.
To donate, pack your machine into its travel bag or plenty of cushioning and send it to SecondWindCPAP, 163 3rd St., Tracy, MN, 56175.
If your machine doesn’t work properly or is more than 10 years old, don’t send it. SecondWind has no way to make repairs, and it’s difficult to reuse models that are more than a decade old, Seager says.
If your machine has been used for 500 or fewer hours, is in excellent mechanical and cosmetic condition and has not been exposed to cigarette smoke, you can ask SecondWind if it is interested in purchasing it. The company’s website has more details about the types of machines it will buy. [ Read Complete Post By Diane Suchetka …. ]
Preeclampsia is a dangerous condition that occurs in about 5% of pregnant women, or about 300,000 women per year. This condition leads to high blood pressure, kidney disease, and headaches, amongst others.
Since 99.9% of western medicine is based on studies that occur only in the daytime, it’s not surprising that sleep may be a common denominator amongst a variety of familiar medical conditions. According to the findings of a research study women with preeclampsia bear 2-3 times increased risk of developing heart disease later on. It’s not too surprising, since obstructive sleep apnea can occur in pregnant women, especially as they gain weight. We know that rapid weight gain is a major risk for sleep apnea. Read the rest of this entry
Findings of a new research study show that the amino acid cysteine may be a biomarker for the development of obstructive sleep apnea (OSA) in obese and nonobese patients.
Brazilian researchers compared plasma levels of cysteine in 75 patients with obstructive sleep apnea (OSA) with 75 control subjects.
Results showed that cysteine plasma levels were higher in patients with obstructive sleep apnea (OSA) compared with the control subjects. A subgroup of lean patients (BMI < 25) with OSA also had higher cysteine levels than the control subjects.
Furthermore, patients with obstructive sleep apnea (OSA) who received continuous positive airway pressure showed a decrease in plasma levels of cysteine after 6 months.
Researchers conclude that cysteine is a potential biomarker for obstructive sleep apnea (OSA) and that obesity does not influence its function as a biomarker.
The article is published in the February issue of Chest, the peer-reviewed journal of the American College of Chest Physicians: Chest 2011; 139(2):246-252.